The Impact of the Rs1044457 Polymorphism in the CMPK1 Gene on the Response Rate to Gemcitabine‐Based Chemotherapy in Metastatic NSCLC Patients
Abstract This study aims to evaluate the role of a specific gene polymorphism, Cytidine/Uridine Monophosphate Kinase 1 (CMPK1) rs1044457, in predicting the response to gemcitabine‐based chemotherapy in patients with NSCLC. A total of 98 NSCLC patients are enrolled in the study. Based on their respon...
Saved in:
Main Authors: | Ghassan Saod Saleh, Fouad Kadhim Gatea, Qasim Sharhan Al‐Mayah, Hayder Lazim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-06-01
|
Series: | Advanced Genetics |
Subjects: | |
Online Access: | https://doi.org/10.1002/ggn2.202400058 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of single nucleotide polymorphisms rs7164665, rs71461059, rs74765750, rs6762529 with sudden cardiac death
by: A. A. Ivanova, et al.
Published: (2019-11-01) -
TMPRSS2 rs2070788 and rs383510 polymorphisms and laboratory markers as predictors for severity and mortality among COVID-19 patients: A single center study
by: Heba Abdel-Gaber, et al.
Published: (2025-08-01) -
CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis
by: YaoMing Zheng, et al.
Published: (2025-01-01) -
Antiviral Intervention of COVID-19: Linkage of Disease Severity with Genetic Markers FGB (rs1800790), NOS3 (rs2070744) and TMPRSS2 (rs12329760)
by: Maksym Sokolenko, et al.
Published: (2025-05-01) -
SINGLE-NUCLEOTIDE POLYMORPHISMS OF THE ESR1 [RS 2234693], IL-1 [RS1143627], RANKL [RS9594738] AND [RS9594759] GENES AS POSSIBLE RISK MARKERS FOR VARIOUS VARIANTS OF THE COURSE OF PERIODONTAL DISEASE IN PATIENTS BORN MACROSOMIC
by: O.V. Garmash
Published: (2020-03-01)